Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01933724 · ClinicalTrials.gov registry record · Phase 3
The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach
A Phase 3 study of Vasculitis and Granulomatosis With Polyangiitis, sponsored by University of South Florida.
- Active
- Registry status
- Phase 3
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT01933724: Active Phase 3 study of Vasculitis and Granulomatosis With Polyangiitis, sponsored by University of South Florida.
NCT01933724 is a Phase 3 study of Vasculitis and Granulomatosis With Polyangiitis that is active but no longer recruiting, run by University of South Florida. The registered enrollment target is 12 participants, below the 27,318-participant average among 11 other Vasculitis trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01933724, a Phase 3 study of Vasculitis and Granulomatosis With Polyangiitis, is active but no longer recruiting, sponsored by University of South Florida.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized controlled trial in patients with a diagnosis of granulomatosis with polyangiitis (GPA; Wegener's)that are in remission to evaluate the effects of using low-dose glucocorticoids ( 5 mg/day of prednisone) as compared to stopping glucocorticoid treatment entirely (0 mg/day of prednisone)on rates of disease relapse/disease flares. This study is a novel approach to conducting a randomized clinical trial in the community setting. This study is being conducted in parallel with a similar study at established vasculitis institutions. This study will have a patient centric approach to research in that subjects will be recruited online and through social media and vasculitis support networks. Participants will be consented online and will receive care through their regular treating physician so no travel or additional doctor visits are required. Study participants will consent to the study and complete online questionnaires about their prednisone dose and about how they are feeling.
Conditions Studied
Interventions
- DRUG 5 mg prednisone
- DRUG 0 mg prednisone
Study Locations (1)
Florida
- University of South Florida TAPIR Study Team - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-02-17 |
| Est. Completion | 2025-12-31 |
| Phase | Phase 3 |
What the registry record for NCT01933724 still lists
NCT01933724 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 27,318-participant average among 11 other Vasculitis trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Vasculitis appearing as the primary indexed condition, and to 2 interventions - of which 5 mg prednisone is the first listed.
NCT01933724 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT01933724 about?
NCT01933724 is a clinical study titled "The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach". This is a randomized controlled trial in patients with a diagnosis of granulomatosis with polyangiitis (GPA; Wegener's)that are in remission to evaluate the effects of using low-dose glucocorticoids ( 5 mg/day of prednisone) as compared to stopping glucocorticoid treatment entirely (0 mg/day of pred...
What is the current status of trial NCT01933724?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 12 participants. The study started on 2014-02-17. Estimated completion is 2025-12-31.
What conditions does trial NCT01933724 study?
This clinical trial studies the following conditions: Vasculitis, Granulomatosis With Polyangiitis, Wegener Granulomatosis.
What interventions are being tested in trial NCT01933724?
The interventions under investigation include: 5 mg prednisone (DRUG), 0 mg prednisone (DRUG).
Who is sponsoring clinical trial NCT01933724?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01933724 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vasculitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01933724's enrollment target sits among peer trials
12 11th of 11 higher than 1 of 11 other Vasculitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vasculitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.
RECRUITING · Phase 3
-
Longitudinal Study for Relapsing Polychondritis
RECRUITING
-
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
RECRUITING · Phase 1
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
RECRUITING
-
Vasculitis Pregnancy Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI